MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats
Comorbidity between post-traumatic stress disorder (PTSD) and alcohol use is common and mutually-reinforcing, yet there are no pharmacological strategies that specifically target trauma-linked escalation of alcohol intake. We evaluated whether 3,4-methylenedioxymethamphetamine (MDMA), given in a therapy-adjunctive fashion (30 min before fear extinction), could facilitate extinction of conditioned fear and reduce alcohol consumption in a rat model that combines fear conditioning, binge-like alcohol access, abstinence, and re-exposure. Inbred alcohol-preferring (iP) and outbred Wistar rats of both sexes underwent auditory fear conditioning, voluntary ethanol drinking, and subsequently fear extinction after MDMA or vehicle administration, with drug-free extinction recall and alcohol consumption assessed thereafter. Fear conditioning increased voluntary alcohol intake only in iP rats, suggesting a genotype-related fear-alcohol contingency. MDMA acutely reduced freezing during extinction, but ultimately reshaped across-session freezing patterns in a strain- and sex-dependent manner. There were no lasting MDMA treatment effects on next-day drug-free recall. MDMA also altered on-drug fear-expression during extinction without affecting later recall in an iP rat cohort without prior alcohol exposure, indicating the effect is not secondary to drinking history. Critically, MDMA prevented the shock-related increase in alcohol consumption but only in iP rats. These data suggest MDMA's most reliable action in this model is to disrupt trauma-linked escalation of alcohol intake in genetically- and experientially- vulnerable rats, rather than to globally enhance fear extinction.
Authors
- Annai J. Charlton
- Kirsten C. Morley (ORCID: https://orcid.org/0000-0002-0868-9928)
- Erin J. Campbell (ORCID: https://orcid.org/0000-0002-4722-6897)
- Leigh C. Walker (ORCID: https://orcid.org/0000-0002-9282-2743)
- Dan I. Lubman (ORCID: https://orcid.org/0000-0002-6747-1937)
- Kade L. Huckstep
- Grace Bailey (ORCID: https://orcid.org/0000-0003-4646-3134)
- Xavier J. Maddern
- Robyn Brown
- Shalini Arunogiri
- Gavan P. McNally
- Amy J. Pearl
- Billi Newton
- Andrew J. Lawrence
Institutions
- The University of Sydney (AU)
- The University of Melbourne (AU)
- Florey Institute of Neuroscience and Mental Health (AU)
- UNSW Sydney (AU)
- Hunter Medical Research Institute (AU)
- Eastern Health (AU)
- Monash University (AU)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- Neuropsychopharmacology
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1038/s41386-026-02394-2
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00